Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen, Di Wu, Wei Guo, +17

Journal of Clinical Investigation

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Tao Chen, Di Wu, Huilong Chen, +18

BMJ

COVID-19 in persons with haematological cancers

Wenjuan He, Lei Chen, Li Chen, +12

Leukemia

MedicineCovid-19 PandemicHematologyHaematological CancersCovid-19 Epidemiology +3

FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression

Jian‐Hua Mao, Il-Jin Kim, Di Wu, +4

Science

Tumor BiologyEnzyme MtorSystems BiologySignaling PathwayHealth Sciences +13

Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations

Yuanyuan Qin, Jinfeng Wu, Tao Chen, +11

Journal of Clinical Investigation

White MatterBrain LesionCovid-19NeuroinflammationCerebral Vascular Regulation +21

Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019

Guang Chen, Di Wu, Wei Guo, +17

Viral DiagnosticsImmunologyCovid-19 EpidemiologyHuanan Seafood MarketCovid-19 +19

Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China

Zhilin Zeng, Haijing Yu, Huilong Chen, +8

Critical Care

Hematological features of persons with COVID-19

Qiubai Li, Yulin Cao, Lei Chen, +16

Leukemia

Covid-19 PandemicHematologyHematological FeaturesChronic Viral InfectionCovid-19 Epidemiology +3

Risk factors for death in 1859 subjects with COVID-19

Lei Chen, Jianming Yu, Wenjuan He, +18

Leukemia

Mortality StudiesVirus EpidemiologyCovid-19 PandemicRiskCovid-19 Epidemiology +5

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma

Yuandeng Luo, Lei Fang, Hongqiang Yu, +14

Journal of Hepatology